JNJ Johnson & Johnson
- 151.220
- +1.310+0.87%
- 151.120
- -0.100-0.07%
Johnson & Johnson News
J&J Scores Lowest Spread of Year on Bonds to Help Fund $13 Billion Bid for Shockwave
By Joy Wiltermuth Wall Street deal-making remains robust despite the Federal Reserve's rate hikes since 2022 Johnson & Johnson sailed through the market on Monday, with a four-part bond to help fund
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
Johnson & Johnson's (NYSE:JNJ) medical device subsidiary is pulling its Megadyne Mega Soft Pediatric Patient Return Electrodes following reports of patient burns.Ethicon's Megadyne division recalled i
J&J's $13 Billion Bid for Shockwave Turns to Wall Street for Funding
By Joy Wiltermuth Wall Street deal making remains robust despite the Federal Reserve's rate hikes since 2022 Johnson & Johnson (JNJ) rolled out a four-part bond on Monday to help fund its planned $1
Top Midday Stories: Return of 'Roaring Kitty' Lifts GameStop Shares; Intel, Apollo Near Deal on Ireland Plant; BHP Latest Offer Rejected by Anglo American; Squarespace Acquired by Permira; Amazon Autonomous Driving Under Probe
The major US indexes were higher at midday Monday as investors ready themselves for a consequential inflation data release on Wednesday. In company news, shares of GameStop (GME) soared in premarket a
14 Best Long-Term Dividend Stocks To Buy Now
Johnson & Johnson (JNJ) Could Be a Great Choice
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition
Johnson & Johnson (JNJ) said Monday it is offering its senior unsecured notes in four tranches to help fund its planned acquisition of Shockwave Medical (SWAV). Closing of the deal is subject to appro
Sector Update: Consumer Stocks Gain Premarket Monday
Consumer stocks were gaining premarket Monday, with the Consumer Discretionary Select Sector SPDR Fund (XLY) and the Consumer Staples Select Sector SPDR Fund (XLP) both up 0.1%. GameStop (GME) shares
Express News | J&J Files for Four-Part Notes Offering; Size Not Disclosed- SEC Filing
Johnson & Johnson (JNJ.US) to clear Kenvue (KVUE.US) shares after one year of divestment
The Zhitong Finance App learned that Kenvue (KVUE.US) announced on Monday that Johnson & Johnson (JNJ.US) will sell all of its 9.5% shares in the company. According to information, Kenvue is a consumer health business company spun off by Johnson & Johnson and was officially listed on the New York Stock Exchange in May 2023. Based on Kenvue's recent closing price, the value of this stock sale was approximately $3.75 billion. Kenvue shares fell nearly 4% in pre-market trading.
Johnson & Johnson to Exit Kenvue in Debt-for-equity Deal
Johnson & Johnson to No Longer Own Kenvue Shares After Proposed Offering Closes
Johnson & Johnson (JNJ) is expected to exchange 182,329,550 shares of Kenvue's (KVUE) common stock for indebtedness of Johnson & Johnson to be held by Goldman Sachs and J.P. Morgan, Kenvue said Monday
We Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its Debt
J&J to Sell All Shares in Spun-off Unit Kenvue
Kenvue Announces Launch of Secondary Offering
Kenvue Inc. (NYSE:KVUE) ("Kenvue") announced today the launch of a secondary underwritten public offering (the "Offering") of 182,329,550 shares of its common stock (the "Shares"). Kenvue is not selling any shares of
Express News | Kenvue Filed For Offering Of 182.3M Shares Of Common Stock By Selling Shareholders
Express News | Kenvue Inc - All 182.3 Mln Shares of Common Stock That Are Being Offered and Sold in the Offering Are Currently Held by Johnson & Johnson
Express News | NYSE Order Imbalance 212666.0 Shares on Buy Side
Express News | FDA: Megadyne Initiates Global Discontinuation and Voluntary Recall of Mega Soft Pediatric Patient Return Electrode
Drugmakers in Medicare Price Negotiations Spent Less on Research Than on Shareholder Payments, Marketing and Overhead: Report
Analysis
Price Target
No Data
